InspireMD Sold 2,734 CGuard EPS Stent Systems In Q3 Compared To 2,624 A Year Ago
Portfolio Pulse from Benzinga Newsdesk
InspireMD reported a sales increase for its CGuard EPS Stent Systems in Q3, selling 2,734 units compared to 2,624 units a year ago.
November 06, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
InspireMD's Q3 sales for its CGuard EPS Stent Systems increased, which may positively impact the company's revenue and potentially its stock price.
The increase in sales of InspireMD's CGuard EPS Stent Systems indicates a positive trend in the company's performance. This could lead to increased revenues for Q3, which may positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100